Cargando…

Prognostic DNA Methylation Markers for Prostate Cancer

Prostate cancer (PC) is the most commonly diagnosed neoplasm and the third most common cause of cancer-related death amongst men in the Western world. PC is a clinically highly heterogeneous disease, and distinction between aggressive and indolent disease is a major challenge for the management of P...

Descripción completa

Detalles Bibliográficos
Autores principales:	Strand, Siri H., Orntoft, Torben F., Sorensen, Karina D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4200823/ https://www.ncbi.nlm.nih.gov/pubmed/25238417 http://dx.doi.org/10.3390/ijms150916544

Ejemplares similares

Heterogeneous patterns of DNA methylation-based field effects in histologically normal prostate tissue from cancer patients
por: Møller, Mia, et al.
Publicado: (2017)

Dysregulation and prognostic potential of 5-methylcytosine (5mC), 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-carboxylcytosine (5caC) levels in prostate cancer
por: Storebjerg, Tine Maj, et al.
Publicado: (2018)

Biomarker potential of ST6GALNAC3 and ZNF660 promoter hypermethylation in prostate cancer tissue and liquid biopsies
por: Haldrup, Christa, et al.
Publicado: (2018)

High levels of 5-hydroxymethylcytosine (5hmC) is an adverse predictor of biochemical recurrence after prostatectomy in ERG-negative prostate cancer
por: Strand, Siri H., et al.
Publicado: (2015)

Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
por: Bjerre, Marianne T., et al.
Publicado: (2019)

Exploring the transcriptome of hormone-naive multifocal prostate cancer and matched lymph node metastases
por: Schmidt, Linnéa, et al.
Publicado: (2018)

Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer
por: Sørensen, K D, et al.
Publicado: (2013)

Novel diagnostic and prognostic classifiers for prostate cancer identified by genome-wide microRNA profiling
por: Kristensen, Helle, et al.
Publicado: (2016)

Identifying aggressive prostate cancer foci using a DNA methylation classifier
por: Mundbjerg, Kamilla, et al.
Publicado: (2017)

RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy
por: Strand, Siri H., et al.
Publicado: (2016)

epiG: statistical inference and profiling of DNA methylation from whole-genome bisulfite sequencing data
por: Vincent, Martin, et al.
Publicado: (2017)

High miR-449b expression in prostate cancer is associated with biochemical recurrence after radical prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2014)

Expression profiling of prostate cancer tissue delineates genes associated with recurrence after prostatectomy
por: Mortensen, Martin Mørck, et al.
Publicado: (2015)

HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer
por: Ross-Adams, Helen, et al.
Publicado: (2016)

The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial
por: Fredsøe, Jacob, et al.
Publicado: (2020)

Perceptions about screening for prostate cancer using genetic lifetime risk assessment: a qualitative study
por: Kirkegaard, Pia, et al.
Publicado: (2018)

Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review
por: Draht, Muriel X. G., et al.
Publicado: (2018)

Histopathological grading and DNA ploidy as prognostic markers in metastatic prostatic cancer.
por: Jørgensen, T., et al.
Publicado: (1995)

Advances in Prognostic Methylation Biomarkers for Prostate Cancer
por: Lam, Dilys, et al.
Publicado: (2020)

Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patients
por: Schmidt, L, et al.
Publicado: (2018)

Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case–control study
por: Ørntoft, Mai-Britt W., et al.
Publicado: (2015)

Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis
por: Nørgaard, Maibritt, et al.
Publicado: (2017)

Epigenetic Analysis of Circulating Tumor DNA in Localized and Metastatic Prostate Cancer: Evaluation of Clinical Biomarker Potential
por: Bjerre, Marianne Trier, et al.
Publicado: (2020)

Oxidative Stress and DNA Methylation in Prostate Cancer
por: Donkena, Krishna Vanaja, et al.
Publicado: (2010)

DNA methylation in repeat negative prostate biopsies as a marker of missed prostate cancer
por: Fiano, Valentina, et al.
Publicado: (2019)

DNA Methylation as Surrogate Marker For Gastric Cancer
por: Oh, Jung-Hwan, et al.
Publicado: (2015)

Epigenetics of prostate cancer: beyond DNA methylation
por: Schulz, W A, et al.
Publicado: (2006)

Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review
por: Hoogland, A. Marije, et al.
Publicado: (2014)

5hmC Level Predicts Biochemical Failure Following Radical Prostatectomy in Prostate Cancer Patients with ERG Negative Tumors
por: Kristensen, Gitte, et al.
Publicado: (2019)

TGF-β mediated DNA methylation in prostate cancer
por: Lee, Chung, et al.
Publicado: (2012)

Prognostic marker and target in prostate cancer
por: Lavorgna, Giovanni, et al.
Publicado: (2015)

Mast Cells as a Potential Prognostic Marker in Prostate Cancer
por: Taverna, Gianluigi, et al.
Publicado: (2013)

Epigenetic markers in circulating cell‐free DNA as prognostic markers for survival of castration‐resistant prostate cancer patients
por: Hendriks, Rianne J., et al.
Publicado: (2018)

A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA
por: Brikun, Igor, et al.
Publicado: (2018)

SMAP: a streamlined methylation analysis pipeline for bisulfite sequencing
por: Gao, Shengjie, et al.
Publicado: (2015)

Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array
por: Tørring, N, et al.
Publicado: (2007)

Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review
por: de Ruijter, Tim C., et al.
Publicado: (2020)

Effectiveness and cost-effectiveness of prognostic markers in prostate cancer
por: Calvert, N W, et al.
Publicado: (2003)

Aberrant DNA Methylation and Prostate Cancer
por: Majumdar, Sunipa, et al.
Publicado: (2011)

DNA Methylation Markers in Lung Cancer
por: Hong, Yoonki, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_h3327f8f929jk2jsn9vts13qdf